Cervico-Vaginal Tissue Ex Vivo as a Model to Study Early Events in HIV-1 Infection
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cervico-Vaginal Tissue Ex Vivo as a Model to Study Early Events in HIV-1 Infection
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
Volume 65, Issue 3, Pages 268-278
Publisher
Wiley
Online
2011-01-12
DOI
10.1111/j.1600-0897.2010.00967.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Candida Infections of the Genitourinary Tract
- (2010) J. M. Achkar et al. CLINICAL MICROBIOLOGY REVIEWS
- IL-8 Decreases HIV-1 Transcription in Peripheral Blood Lymphocytes and Ectocervical Tissue Explants
- (2010) Christiane Rollenhagen et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial
- (2010) Jairam R Lingappa et al. LANCET
- After CAPRISA 004: time to re-evaluate the HIV lexicon
- (2010) Willard Cates LANCET
- Effect of treating co-infections on HIV-1 viral load: a systematic review
- (2010) Kayvon Modjarrad et al. LANCET INFECTIOUS DISEASES
- HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model
- (2010) E Saba et al. Mucosal Immunology
- Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus
- (2010) C R Wira et al. Mucosal Immunology
- Targeting early infection to prevent HIV-1 mucosal transmission
- (2010) Ashley T. Haase NATURE
- In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 Microbicide
- (2010) Lisa C. Rohan et al. PLoS One
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
- (2010) Q. Abdool Karim et al. SCIENCE
- Identifying and characterizing recently transmitted viruses
- (2010) Brandon F Keele Current Opinion in HIV and AIDS
- Caveats associated with the use of human cervical tissue for HIV and microbicide research
- (2009) Deborah J Anderson et al. AIDS
- War and Peace between Microbes: HIV-1 Interactions with Coinfecting Viruses
- (2009) Andrea Lisco et al. Cell Host & Microbe
- HIV Type 1 Infection in Women: Increased Transcription of HIV Type 1 in Ectocervical Tissue Explants
- (2009) Susana N. Asin et al. JOURNAL OF INFECTIOUS DISEASES
- Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies
- (2009) Marie-Claude Boily et al. LANCET INFECTIOUS DISEASES
- Toxoplasma gondii inhibits R5 HIV-1 replication in human lymphoid tissues ex vivo
- (2009) Atfa Sassi et al. MICROBES AND INFECTION
- Use of human tissue explants to study human infectious agents
- (2009) Jean-Charles Grivel et al. Nature Protocols
- High replication fitness and transmission efficiency of HIV-1 subtype C from India: Implications for subtype C predominance
- (2009) Milka A. Rodriguez et al. VIROLOGY
- Genetic and antigenic features of the transmitted virus
- (2009) Brandon F Keele et al. Current Opinion in HIV and AIDS
- Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man
- (2009) Jean K. Lim et al. PLoS Pathogens
- Coinfecting viruses as determinants of HIV disease
- (2009) Andrea Lisco et al. Current HIV/AIDS Reports
- HIV infection of the genital mucosa in women
- (2009) Florian Hladik et al. Current HIV/AIDS Reports
- Upregulation of Human Cytomegalovirus by HIV Type 1 in Human Lymphoid Tissue ex Vivo
- (2008) Angélique Biancotto et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Herpes Simplex: Insights on Pathogenesis and Possible Vaccines
- (2008) David M. Koelle et al. Annual Review of Medicine
- Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor
- (2008) P. Fletcher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Acyclovir Is Activated into a HIV-1 Reverse Transcriptase Inhibitor in Herpesvirus-Infected Human Tissues
- (2008) Andrea Lisco et al. Cell Host & Microbe
- TNF-α and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo
- (2008) Marein A.W.P. de Jong et al. JOURNAL OF CLINICAL INVESTIGATION
- Cyanovirin-N potently inhibits human immunodeficiency virus type 1 infection in cellular and cervical explant models
- (2008) V. Buffa et al. JOURNAL OF GENERAL VIROLOGY
- Candidate Microbicide PPCM Blocks Human Immunodeficiency Virus Type 1 Infection in Cell and Tissue Cultures and Prevents Genital Herpes in a Murine Model
- (2008) P. M. M. Mesquita et al. JOURNAL OF VIROLOGY
- Herpes simplex virus and HIV-1: deciphering viral synergy
- (2008) Philippe Van de Perre et al. LANCET INFECTIOUS DISEASES
- Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV Transmission
- (2008) Lut Van Damme et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted Delivery of PSC-RANTES for HIV-1 Prevention using Biodegradable Nanoparticles
- (2008) Anthony S. Ham et al. PHARMACEUTICAL RESEARCH
- Preclinical evaluation of lime juice as a topical microbicide candidate
- (2008) Patricia S Fletcher et al. Retrovirology
- New players in cytokine control of HIV infection
- (2008) Massimo Alfano et al. Current HIV/AIDS Reports
- Current concepts of HIV transmission
- (2008) Gavin Morrow et al. Current Infectious Disease Reports
- Antiretroviral Drug–Based Microbicides to Prevent HIV-1 Sexual Transmission
- (2007) Per Johan Klasse et al. Annual Review of Medicine
- Establishment and validation of an ex vivo human cervical tissue model for local delivery studies
- (2007) Christian Hiller et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started